| Literature DB >> 3810040 |
T Sheehan, M Judge, A C Parker.
Abstract
Impressive results have recently been reported in 29 cases of advanced refractory myeloma treated with 4-d infusions of Vincristine and Adriamycin (VAD). We report our own experience with this protocol in 13 cases of myeloma and related lymphoproliferative disorders. In 2 of these cases, VAD was used as first line treatment. Objective responses were seen in two-thirds of cases and the major complication of therapy was infection, predominantly bacterial in nature.Entities:
Mesh：
Substances：
Year: 1986 PMID： 3810040 DOI： 10.1111/j.1600-0609.1986.tb02632.x
Source DB: PubMed Journal: Scand J Haematol ISSN： 0036-553X